Metabolic alterations in patients with Parkinson disease and visual hallucinations

被引:94
作者
Boecker, Henning
Ceballos-Baumann, Andres O.
Volk, Dominik
Conrad, Bastian
Forstl, Hans
Haussermann, Peter
机构
[1] Tech Univ Munich, Dept Nucl Med, D-8000 Munich, Germany
[2] Tech Univ Munich, Dept Neurol, D-8000 Munich, Germany
[3] Tech Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[4] Univ Kiel, Dept Psychiat, D-2300 Kiel, Germany
关键词
D O I
10.1001/archneur.64.7.984
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Visual hallucinations ( VHs) occur frequently in advanced stages of Parkinson disease ( PD). Which brain regions are affected in PD with VH is not well understood. Objectives: To characterize the pattern of affected brain regions in PD with VH and to determine whether functional changes in PD with VH occur preferentially in visual association areas, as is suggested by the complex clinical symptomatology. Design: Positron emission tomography measurements using fluorodeoxyglucose F 18. Between-group statistical analysis, accounting for the variance related to disease stage. Setting: University hospital. Patients: Eight patients with PD and VH and 11 patients with PD without VH were analyzed. The presence of VH during the month before positron emission tomography was rated using the Neuropsychiatric Inventory subscale for VH ( PD and VH, 4.63; PD without VH, 0.00; P < .002). Results: Parkinson disease with VH, compared with PD without VH, was characterized by reduction in the regional cerebral metabolic rate for glucose consumption ( P < .05, corrected for false discovery rate) in occipito-temporoparietal regions, sparing the occipital pole. No significant increase in regional glucose metabolism was detected in patients with PD and VH. Conclusions: The pattern of resting-state metabolic changes in regions of the dorsal and ventral visual streams, but not in primary visual cortex, in patients with PD and VH, is compatible with the functional roles of visual association areas in higher-order visual processing. These findings may help to further elucidate the functional mechanisms underlying VH in PD.
引用
收藏
页码:984 / 988
页数:5
相关论文
共 36 条
[1]
Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing [J].
Abe, Y ;
Kachi, T ;
Kato, T ;
Arahata, Y ;
Yamada, T ;
Washimi, Y ;
Iwai, K ;
Ito, K ;
Yanagisawa, N ;
Sobue, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (04) :419-422
[2]
VISUAL HALLUCINATIONS IN THE ELDERLY ASSOCIATED WITH THE USE OF LEVODOPA [J].
BANERJEE, AK ;
FALKAI, PG ;
SAVIDGE, M .
POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (764) :358-361
[3]
Visual hallucinations in Parkinson's disease: a review and phenomenological survey [J].
Barnes, J ;
David, AS .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (06) :727-733
[4]
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: A case series [J].
Bullock, R ;
Cameron, A .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (05) :258-264
[5]
Visual hallucinosis: The major clinical determinant of distorted chromatic contour perception in Parkinson's disease [J].
Buttner, T ;
Kuhn, W ;
Muller, T ;
Welter, FL ;
Federlein, J ;
Heidbrink, K ;
Przuntek, H .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (10) :1195-1204
[6]
PATHOLOGICAL-CHANGES IN THE NUCLEUS OF MEYNERT IN ALZHEIMERS AND PARKINSONS DISEASES [J].
CANDY, JM ;
PERRY, RH ;
PERRY, EK ;
IRVING, D ;
BLESSED, G ;
FAIRBAIRN, AF ;
TOMLINSON, BE .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 59 (02) :277-289
[7]
Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest:: differential correlates with ratings of anxiety [J].
Conca, A ;
Fritzsche, H ;
Peschina, W ;
König, P ;
Swoboda, E ;
Wiederin, H ;
Haas, C .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2000, 98 (01) :43-+
[8]
Cortical fMRI activation produced by attentive tracking of moving targets [J].
Culham, JC ;
Brandt, SA ;
Cavanagh, P ;
Kanwisher, NG ;
Dale, AM ;
Tootell, RBH .
JOURNAL OF NEUROPHYSIOLOGY, 1998, 80 (05) :2657-2670
[9]
The neuropsychiatric inventory: Assessing psychopathology in dementia patients [J].
Cummings, JL .
NEUROLOGY, 1997, 48 (05) :S10-S16
[10]
Diederich NJ, 1998, CLIN NEUROPHARMACOL, V21, P289